Skip to main content
Pei-Ling Chen, MD, Pathology, Saint Louis, MO

Pei-LingChenMD

Pathology • Saint Louis, MO

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Are you Dr. Chen?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 23 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    660 S Euclid Ave
    Saint Louis, MO 63110
    Phone+1 314-747-3000

Summary

  • Dr. Pei-Ling Chen, MD is a board certified pathologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri and Florida. She is affiliated with H. Lee Moffitt Cancer Center and Research Institute.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2010 - 2014
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2003
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • MO State Medical License
    MO State Medical License 2016 - 2017
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Press Mentions

  • Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New Therapies
    Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New TherapiesMarch 1st, 2022
  • Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell Lymphoma
    Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell LymphomaMarch 1st, 2022

Dr. Pei-Ling Chen, Dr. Pei-Ling Chen, MD, Dr. P Chen